DANVERS, Mass., June 3, 2014 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported that physicians have implanted more than 20,000 Impella® pumps in U.S. patients requiring hemodynamic support. The 20,000th Impella procedure took place at Keck Medicine of University of Southern California (USC) hospital. To date, the higher flow Impella CP® has been implanted in over 3,000 U.S. patients, with the 3,000th procedure taking place at Hoag Memorial Hospital Presbyterian.
Help employers find you! Check out all the jobs and post your resume.
